Delivery Order SPE2DB22D1017-SPE2DB24FF4WB
Award Date 3/25/24
Potential Completion Date 3/26/24
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a $23,478.45 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) for the supply of GLATOPA 40 MG/ML syringes. The award has no set-aside designation. Amerisourcebergen Drug Corp holds a single-award indefinite delivery contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle...
- This federal contract award is a delivery order valued at $13,340.83 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award was issued by the Defense Logistics Agency (DLA), a defense agency, for the supply of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price pricing type and runs through February 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,377.68 Firm Fixed Price delivery order is for the supply of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has a period of performance through May 10, 2022 and does not include any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
- This federal contract award is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,189.76 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 27, 2023 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award, valued at $1,385.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, for the delivery of GLATOPA 40 MG/ML SYRINGEML pharmaceutical products. The $3,600.00 firm fixed price delivery order has a completion date of December 20, 2023. Amerisourcebergen Drug Corporation has extensive experience as a prime contractor providing pharmaceuticals, medical supplies, and distribution services to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the provision of GLATOPA 20 MG/ML SYRINGEML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price of $5,780.28 and a period of performance ending on October 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of GLATOPA 20 MG/ML SYRINGE/ML, with a potential value of $1,577.13. The contract has a completion date of November 15, 2022 and was awarded on November 14, 2022. No set-aside designation was used. Amerisourcebergen Drug Corp,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4563034111 - GLATOPA 40 MG/ML SYRINGEML. The contract has a ceiling value of $36,415.17 and an ultimate completion date of December 8, 2023. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $18,030.03 firm fixed price delivery order is for the supply of GLATIRAMER 40 MG/ML SYRINGEML, a specialty pharmaceutical product, to support the requirements of the Defense Logistics Agency (DLA) Troop Support Medical. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to $999,999,999.00 through...